KCC2 Dysfunction Mediated by Microglial BDNF / TrkB Signaling Exacerbates Early Post‐Stroke Seizure Susceptibility
CNS Neuroscience & Therapeutics · 2026-02 · 32 (2)
DOI: 10.1002/cns.70795 ↗Kurz gefasst
Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 13.02.2026. Verfasst von Jing Zhou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery and Neurology, Institutes of Brain Science, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brai…. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Symporters, Microglia, Receptor, trkB. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Shenzhen Key Medical Discipline Construction Fund, National Natural Science Foundation of China, Shanghai Municipal Science and Technology Major project.
Themen: Schlaganfall
Abstract (Originalsprache)
Background
Post‐stroke seizures are a common and debilitating complication with limited therapeutic options, underscoring the need to identify novel molecular targets. Disruption of chloride homeostasis via impaired potassium chloride cotransporter 2 (KCC2) activity is a key driver of neuronal hyperexcitability. While microglia are a predominant source of brain‐derived neurotrophic factor (BDNF) in the acute phase after brain injury, the role of microglial BDNF and its signaling in KCC2 dysregulation and early post‐stroke seizure susceptibility remain poorly defined.
Methods
Using a middle cerebral artery occlusion‐reperfusion (MCAO‐R) mouse model and oxygen–glucose deprivation/reoxygenation (OGD/R) in hippocampal neurons, we assessed KCC2 function, neuronal excitability, and seizure susceptibility. Pharmacological tools, including the microglial inhibitor minocycline, the TrkB antagonist K252a, the loop diuretic furosemide (FUR), repurposed here as a KCC2‐stabilizing agent, and the KCC2 activator CLP290, were employed. Techniques included immunofluorescence, Western blotting, patch‐clamp electrophysiology, electroencephalography (EEG), and behavioral seizure assessment.
Results
MCAO‐R and OGD/R significantly reduced membrane KCC2 expression, leading to a depolarizing shift in the GABA equilibrium potentials ( E GABA ), diminished GABAergic inhibition, and increased neuronal excitability. Preventing KCC2 downregulation with FUR or CLP290 suppressed epileptiform activity in vitro and increased seizure thresholds in vivo. Ischemia induced robust microglial activation and increased BDNF release. Pharmacological inhibition of microglia (minocycline) or TrkB (K252a) effectively restored KCC2 expression, normalized E GABA , and reduced post‐stroke seizure severity.
Conclusion
Our findings identify microglia‐derived BDNF/TrkB signaling as a critical upstream pathway mediating KCC2 dysfunction in early post‐stroke seizure. Targeting this axis by inhibiting microglial activation, blocking TrkB, or directly enhancing KCC2 function with activators like CLP290 represents a promising therapeutic strategy for stroke‐related epilepsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery and Neurology, Institutes of Brain Science, State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institute of Biological Science, Zhongshan Hospital, Fudan…
- Hangzhou Linping District Integrated Traditional Chinese and Western Medicine Hospital, Hangzhou, Zhejiang, China.
- Department of Rehabilitation, the First Affiliated Hospital of Shenzhen University/Shenzhen Second People's Hospital, Shenzhen, China.
ORCID-Profile: Jing Zhou, Jingyi Cai
Förderung
- Shenzhen Key Medical Discipline Construction Fund
- National Natural Science Foundation of China
- Shanghai Municipal Science and Technology Major project
- Sanming Project of Medicine in Shenzen Municipality
- Science, Technology and Innovation Commission of Shenzhen Municipality
- Xiyuan Project of the Fudan University Undergraduate Research Opportunities Program
Zitieren
APA
Zhou, J., Wang, B. H., Yu, J., Wang, G., Cai, J., Yu, M., Chen, K., Wan, L., Liu, X., Yang, Z., Wang, Y., & Wang, Y. (2026). KCC2 Dysfunction Mediated by Microglial BDNF / TrkB Signaling Exacerbates Early Post‐Stroke Seizure Susceptibility. CNS Neuroscience & Therapeutics, 32(2). https://doi.org/10.1002/cns.70795
Vancouver
Zhou J, Wang BH, Yu J, Wang G, Cai J, Yu M, et al. KCC2 Dysfunction Mediated by Microglial BDNF / TrkB Signaling Exacerbates Early Post‐Stroke Seizure Susceptibility. CNS Neuroscience & Therapeutics. 2026;32(2). doi:10.1002/cns.70795
BibTeX
@article{Zhou2026,
author = {Zhou, Jing and Wang, Benjamin H and Yu, Jiangning and Wang, Guoxiang and Cai, Jingyi and Yu, Mohan and Chen, Kehua and Wan, Li and Liu, Xu and Yang, Zhigang and Wang, Yulong and Wang, Yun},
title = {KCC2 Dysfunction Mediated by Microglial BDNF / TrkB Signaling Exacerbates Early Post‐Stroke Seizure Susceptibility},
journal = {CNS Neuroscience & Therapeutics},
year = {2026},
volume = {32},
number = {2},
doi = {10.1002/cns.70795}
}
EUVIMED